US Health Care Spending by Payer and Health Condition, 1996-2016
Open accessAbstract
Importance: US health care spending has continued to increase and now accounts for 18% of the US economy, although little is known about how spending on each health condition varies by payer, and how these amounts have changed over time. Objective: To estimate US spending on health care according to 3 types of payers (public insurance [including Medicare, Medicaid, and other government programs], private insurance, or out-of-pocket payments) and by health condition, age group, sex, and type of care for 1996 through 2016. Design and Setting: Government budgets, insurance claims, facility records, household surveys, and official US records from 1996 through 2016 were collected to estimate spending for 154 health conditions. Spending growth rates (standardized by population size and age group) were calculated for each type of payer and health condition. Exposures: Ambulatory care, inpatient care, nursing care facility stay, emergency department care, dental care, and purchase of prescribed pharmaceuticals in a retail setting. Main Outcomes and Measures: National spending estimates stratified by health condition, age group, sex, type of care, and type of payer and modeled for each year from 1996 through 2016. Results: Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of gross domestic product [GDP]; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person); 85.2% of that spending was included in this study. In 2016, an estimated 48.0% (95% CI, 48.0%-48.0%) of health care spending was paid by private insurance, 42.6% (95% CI, 42.5%-42.6%) by public insurance, and 9.4% (95% CI, 9.4%-9.4%) by out-of-pocket payments. In 2016, among the 154 conditions, low back and neck pain had the highest amount of health care spending with an estimated $134.5 billion (95% CI, $122.4-$146.9 billion) in spending, of which 57.2% (95% CI, 52.2%-61.2%) was paid by private insurance, 33.7% (95% CI, 30.0%-38.4%) by public insurance, and 9.2% (95% CI, 8.3%-10.4%) by out-of-pocket payments. Other musculoskeletal disorders accounted for the second highest amount of health care spending (estimated at $129.8 billion [95% CI, $116.3-$149.7 billion]) and most had private insurance (56.4% [95% CI, 52.6%-59.3%]). Diabetes accounted for the third highest amount of the health care spending (estimated at $111.2 billion [95% CI, $105.7-$115.9 billion]) and most had public insurance (49.8% [95% CI, 44.4%-56.0%]). Other conditions estimated to have substantial health care spending in 2016 were ischemic heart disease ($89.3 billion [95% CI, $81.1-$95.5 billion]), falls ($87.4 billion [95% CI, $75.0-$100.1 billion]), urinary diseases ($86.0 billion [95% CI, $76.3-$95.9 billion]), skin and subcutaneous diseases ($85.0 billion [95% CI, $80.5-$90.2 billion]), osteoarthritis ($80.0 billion [95% CI, $72.2-$86.1 billion]), dementias ($79.2 billion [95% CI, $67.6-$90.8 billion]), and hypertension ($79.0 billion [95% CI, $72.6-$86.8 billion]). The conditions with the highest spending varied by type of payer, age, sex, type of care, and year. After adjusting for changes in inflation, population size, and age groups, public insurance spending was estimated to have increased at an annualized rate of 2.9% (95% CI, 2.9%-2.9%); private insurance, 2.6% (95% CI, 2.6%-2.6%); and out-of-pocket payments, 1.1% (95% CI, 1.0%-1.1%). Conclusions and Relevance: Estimates of US spending on health care showed substantial increases from 1996 through 2016, with the highest increases in population-adjusted spending by public insurance. Although spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for the highest amounts of spending, the payers and the rates of change in annual spending growth rates varied considerably.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
1 of 9 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
- Findingown data
In 2016, 33.7% of low back and neck pain spending was paid by public insurance.
“33.7% (95% CI, 30.0%-38.4%) by public insurance”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“33.7% (95% CI, 30.0%-38.4%)paid by public insurance”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
- Findingown data
In 2016, urinary diseases had estimated health care spending of $86.0 billion.
“urinary diseases ($86.0 billion [95% CI, $76.3-$95.9billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“urinary diseases at $86.0 billion (95% CI, $76.3 billion-$95.9billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
After adjusting for inflation, population size, and age groups, out-of-pocket payments increased at an annualized rate of 1.1% from 1996 to 2016.
“and out-of-pocket payments, 1.1% (95% CI, 1.0%-1.1%)”
Quote in the paperSubstantial claim - Findingown data
In 2016, an estimated 9.4% of health care spending was paid by out-of-pocket payments.
“9.4% (95% CI, 9.4%-9.4%)by out-of-pocket payments”
- Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
“an estimated $255.2 billion (95% CI, $255.0 billion-$255.2billion) or 9.4% (95% CI, 9.4%-9.4%)by out-of-pocket payments”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
- Findingown data
In 2016, diabetes had the third highest health care spending, estimated at $111.2 billion.
“Diabetes accounted for the third highest amount of the health care spending (estimated at $111.2 billion [95% CI, $105.7-$115.9billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“diabetes at $111.2 billion (95% CI, $105.7 billion-$115.9billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingnone given
In 2016, government administration and net cost of insurance programs was 9.8% (range, 8.9%-10.5%) of spending.
“government administration and net cost of insurance programs was 9.8% (range, 8.9%-10.5%) in 2016.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, falls had estimated health care spending of $87.4 billion.
“falls ($87.4 billion [95% CI, $75.0-$100.1 billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“falls at $87.4 billion (95% CI, $75.0 billion-$100.1 billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
- Findingown data
In 2016, an estimated 48.0% of health care spending was paid by private insurance.
“In 2016, an estimated 48.0% (95% CI, 48.0%-48.0%) of health care spending was paid by private insurance”
- Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
“In 2016, an estimated $1.3 trillion (95% CI, $1.3 trillion-$1.3trillion) or 48.0%(95% CI, 48.0%-48.0%) of total spending was accounted for by private insurance”
Quote in the paperSubstantial claim - Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
- Findingown data
In 2016, hypertension had estimated health care spending of $79.0 billion.
“hypertension ($79.0 billion [95% CI, $72.6-$86.8billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“hypertension at $79.0 billion (95% CI, $72.6 billion-$86.8billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
In 2016, ischemic heart disease had estimated health care spending of $89.3 billion.
“ischemic heart disease ($89.3 billion [95% CI, $81.1-$95.5 billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“ischemic heart disease at $89.3 billion (95% CI, $81.1 billion-$95.5 billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
In 2016, an estimated 42.6% of health care spending was paid by public insurance.
“42.6% (95% CI, 42.5%-42.6%)by public insurance”
- Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
“an estimated $1.2 trillion (95% CI, $1.2 trillion-$1.2trillion) or 42.6% (95% CI, 42.5%-42.6%)by public insurance”
Quote in the paperSubstantial claim - Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
- Findingown data
In 2016, most spending on diabetes was paid by public insurance (49.8%).
“and most had public insurance (49.8% [95% CI, 44.4%-56.0%])”
Quote in the paperNot a substantial claim - Findingown data
After adjusting for inflation, population size, and age groups, public insurance spending increased at an annualized rate of 2.9% from 1996 to 2016.
“After adjusting for changes in inflation, population size, and age groups, public insurance spending was estimated to have increased at an annualized rate of 2.9% (95% CI, 2.9%-2.9%)”
Quote in the paperSubstantial claim - Findingown data
Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of GDP; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person).
“Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of gross domestic product [GDP]; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person)”
- Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
“Total health care spending increased from an estimated $1.4 trillion in 1996 (13.3% of gross domestic product [GDP]; $5259 per person) to an estimated $3.1 trillion in 2016 (17.9% of GDP; $9655 per person).”
Quote in the paperSubstantial claim - Also stated in: § Health Care Spending by Payer, Age, and Aggregated Health Condition in 2016 · hedged
- Findingown data
In 2016, other musculoskeletal disorders had the second highest health care spending, estimated at $129.8 billion.
“Other musculoskeletal disorders accounted for the second highest amount of health care spending (estimated at $129.8 billion [95% CI, $116.3-$149.7 billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“the health condition estimated to have the next highest health care spending was other musculoskeletal disorders (including joint and limb pain, myalgia, and osteoporosis) at $129.8 billion (95% CI, $116.3 billion-$149.7 billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
After adjusting for inflation, population size, and age groups, private insurance spending increased at an annualized rate of 2.6% from 1996 to 2016.
“private insurance, 2.6% (95% CI, 2.6%-2.6%)”
Quote in the paperSubstantial claim - Findingown data
In 2016, dementias had estimated health care spending of $79.2 billion.
“dementias ($79.2 billion [95% CI, $67.6-$90.8billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“dementias at $79.2 billion (95% CI, $67.6 billion-$90.8billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
- Findingown data
In 2016, among 154 conditions, low back and neck pain had the highest health care spending, estimated at $134.5 billion.
“In 2016, among the 154 conditions, low back and neck pain had the highest amount of health care spending with an estimated $134.5 billion (95% CI, $122.4-$146.9 billion) in spending”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“In 2016, among the 154 conditions, low back and neck pain had the highest health care spending with an estimated $134.5 billion (95% CI, $122.4-$146.9 billion) in spending”
Quote in the paperSubstantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
In 2016, osteoarthritis had estimated health care spending of $80.0 billion.
“osteoarthritis ($80.0 billion [95% CI, $72.2-$86.1 billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“osteoarthritis at $80.0 billion (95% CI, $72.2 billion-$86.1 billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
In 2016, cardiovascular diseases was the aggregated health category with the third highest spending, estimated at $255.1 billion.
“Cardiovascular diseases was the aggregated health category with the third highest spending in 2016, estimated to be $255.1 billion (95% CI, $233.4 billion-$282.6 billion).”
Quote in the paperNot a substantial claim - Findingown data
In 2016, skin and subcutaneous diseases had estimated health care spending of $85.0 billion.
“skin and subcutaneous diseases ($85.0 billion [95% CI, $80.5-$90.2billion])”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
“skin and subcutaneous diseases at $85.0 billion (95% CI, $80.5 billion-$90.2billion)”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · hedged
- Findingown data
In 2016, spending on diabetes, urogenital, blood, and endocrine disorders was the aggregated health category with the second highest spending, estimated at $309.1 billion.
“Spending on diabetes, urogenital, blood, and endocrine disorders was the aggregated health category with the second highest spending in 2016, estimated to be $309.1 billion (95% CI, $292.4 billion-$328.4billion)”
Quote in the paperNot a substantial claim - Findingown data
In 2016, 57.2% of low back and neck pain spending was paid by private insurance.
“of which 57.2% (95% CI, 52.2%-61.2%)was paid by private insurance”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“of which 57.2% (95% CI, 52.2%-61.2%)was paid by private insurance”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
- Findingown data
In 2016, the aggregated health category with the highest modeled spending was musculoskeletal disorders, estimated at $380.9 billion.
“In 2016, the aggregated health category with the highest modeled spending was musculoskeletal disorders with an estimated $380.9 billion (95% CI, $360.0 billion-$405.4billion) (Table 1).”
Quote in the paperNot a substantial claim - Findingown data
In 2016, 9.2% of low back and neck pain spending was paid by out-of-pocket payments.
“9.2% (95% CI, 8.3%-10.4%)by out-of-pocket payments”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“9.2% (95% CI, 8.3%-10.4%)paid by out-ofpocket payments”
Quote in the paperNot a substantial claim - Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
- Findingown data
In 2016, most spending on other musculoskeletal disorders was paid by private insurance (56.4%).
“and most had private insurance (56.4% [95% CI, 52.6%-59.3%])”
Quote in the paperNot a substantial claim - Findingown data
Spending on diabetes increased substantially.
“Spending on dementias and diabetes also increased substantially.”
Quote in the paperNot a substantial claim - Findingreasoning
Spending on dementias was substantially higher among women than men.
“substantially higher spending among women than men”
Quote in the paperNot a substantial claim - Findingown data
By 2016, out-of-pocket payments accounted for 9.4% of total health spending.
“and 9.4% (95% CI, 9.4%-9.4%)by out-of-pocket payments.”
Quote in the paperSubstantial claim - Findingown data
A relatively large fraction of low back and neck pain spending was associated with working-aged adults.
“a relatively large fraction of the spending was associated with working-aged adults.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, ischemic heart disease was among the health conditions with the highest spending funded by public insurance, with estimated spending of $48.2 billion (95% CI, $43 billion-$54.6 billion).
“ischemic heart disease (an estimated $48.2 billion [95% CI, $43 billion-$54.6billion])”
Quote in the paperNot a substantial claim - Findingown data
Spending on skin and subcutaneous disorders was similar at all ages.
“Figure 4A shows that spending on skin and subcutaneous disorders was similar at all ages”
Quote in the paperNot a substantial claim - Findingown data
In 2016, the health conditions with the highest private insurance spending were low back and neck pain and other musculoskeletal disorders.
“the health conditions with the highest private insurance spending were low back and neck pain and other musculoskeletal disorders”
Quote in the paperSubstantial claim - Findingnone given
A relatively large fraction of spending on falls was out-of-pocket payments.
“A relatively large fraction of this was out-of-pocket payments.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, diabetes was among the health conditions with the highest spending funded by public insurance, with estimated spending of $55.4 billion (95% CI, $49.3 billion-$62.7 billion).
“In 2016, the health conditions with the highest spending funded by public insurance were diabetes (an estimated $55.4 billion [95% CI, $49.3 billion-$62.7 billion])”
Quote in the paperSubstantial claim - Findingown data
After adjusting for inflation, population size, and age groups, public insurance spending increased at an annualized rate of 2.9% between 1996 and 2016.
“After adjusting for changes in inflation, population size, and age groups, health care spending was estimated to have increased between 1996 and 2016 at an annualized rate of 2.9% (95% CI, 2.9%-2.9%)for public insurance”
Quote in the paperSubstantial claim - Findingown data
HIV/AIDS had an annual private insurance spending growth rate of 10.8% (95% CI, 4.2%-19.9%).
“HIV/AIDS (10.8% [95% CI, 4.2%-19.9%])”
Quote in the paperSubstantial claim - Findingown data
In 2016, pregnancy and postpartum care was among the health conditions with the highest spending funded by private insurance, with estimated spending of $52.8 billion (95% CI, $46.4 billion-$59.4 billion).
“pregnancy and postpartum care (an estimated $52.8 billion [95% CI, $46.4 billion-$59.4billion])”
Quote in the paperNot a substantial claim - Findingown data
In 2016, other musculoskeletal disorders was among the health conditions with the highest spending funded by private insurance, with estimated spending of $73.3 billion (95% CI, $62.2 billion-$87.5 billion).
“other musculoskeletal disorders (an estimated $73.3 billion [95% CI, $62.2 billion-$87.5 billion])”
Quote in the paperNot a substantial claim - Findingown data
Public insurance paid 7.7% of dental care.
“whereas 7.7% (95% CI, 7.7%-7.7%)was for dental care.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, dementias was among the health conditions with the highest spending paid by out-of-pocket payments, with estimated spending of $19.4 billion (95% CI, $7.2 billion-$31.7 billion).
“dementias (an estimated $19.4 billion [95% CI, $7.2 billion-$31.7 billion])”
Quote in the paperNot a substantial claim - Findingown data
For falls, spending was greater on women than men at the oldest ages.
“with more spending on women than men at the oldest ages”
Quote in the paperNot a substantial claim - Findingown data
After adjusting for inflation, population size, and age groups, out-of-pocket payments increased at an annualized rate of 1.1% between 1996 and 2016.
“and 1.1% (95% CI, 1.0%-1.1%)for out-of-pocket payments”
Quote in the paperSubstantial claim - Findingown data
Among the 10 health conditions with the highest spending, other musculoskeletal disorders, hypertension, low back and neck pain, skin and subcutaneous diseases, and urinary diseases had the highest fraction of spending during ambulatory care.
“Among those same 10 health conditions, other musculoskeletal disorders, hypertension, low back and neck pain, skin and subcutaneous diseases, and urinary diseases had the highest fraction of spending during ambulatory care”
Quote in the paperNot a substantial claim - Findingown data
Across 1996-2016, out-of-pocket payments were 4.5% of ED care.
“with little spending paid by out-of-pocket payments (4.2% [95% CI, 4.2%-4.2%]and 4.5% [95% CI, 4.5%-4.5%],respectively).”
Quote in the paperNot a substantial claim - Findingown data
The health conditions with the highest modeled spending varied by payer.
“Figure 5 shows that the health conditions with the highest modeled spending for each payer varied.”
Quote in the paperNot a substantial claim - Findingown data
Spending for hypertension is roughly even among men and women.
“roughly even among men and women”
Quote in the paperNot a substantial claim - Findingown data
Among the 10 health conditions with the highest spending, osteoarthritis and ischemic heart disease had the highest fraction of spending during inpatient care.
“osteoarthritis and ischemic heart disease had the highest fraction of spending during inpatient care”
Quote in the paperNot a substantial claim - Findingown data
By 2016, public insurance accounted for 42.6% of total health spending.
“By 2016, the proportion of total health spending was 42.6% (95% CI, 42.5%-42.6%)accounted for by public insurance”
Quote in the paperNot a substantial claim - Findingown data
Among the 10 health conditions with the highest spending, diabetes had the highest fraction of spending on prescribed pharmaceuticals.
“diabetes had the highest fraction of spending on prescribed pharmaceuticals”
Quote in the paperNot a substantial claim - Findingown data
Spending on osteoarthritis was higher among women.
“Figure 4B shows spending was higher among women with osteoarthritis”
Quote in the paperNot a substantial claim - Findingown data
Spending on skin and subcutaneous disorders was higher among women.
“with higher spending among women and among those with private insurance”
Quote in the paperNot a substantial claim - Findingnone given
A substantial amount of spending for nursing care facility stays was paid by out-of-pocket payments.
“Because a substantial amount of spending for nursing care facility stays was paid by out-ofpocket payments”
Quote in the paperSubstantial claim - Findingown data
Spending on skin and subcutaneous disorders was higher among those with private insurance.
“with higher spending among women and among those with private insurance”
Quote in the paperNot a substantial claim - Findingown data
In 2016, other musculoskeletal disorders was among the health conditions with the highest spending funded by public insurance, with estimated spending of $46.9 billion (95% CI, $42 billion-$52.6 billion).
“other musculoskeletal disorders (an estimated $46.9 billion [95% CI, $42 billion-$52.6billion])”
Quote in the paperNot a substantial claim - Findingown data
In 2016, oral disorders was among the health conditions with the highest spending paid by out-of-pocket payments, with estimated spending of $30.5 billion (95% CI, $29.1 billion-$32 billion).
“oral disorders (an estimated $30.5 billion [95% CI, $29.1 billion-$32 billion])”
Quote in the paperNot a substantial claim - Findingown data
Across 1996-2016, 48.8% of inpatient care was paid by public insurance.
“Across this period, 48.8% (95% CI, 48.8%-48.8%) of inpatient care”
Quote in the paperNot a substantial claim - Findingown data
Spending on low back and neck pain increased by 6.7% annually between 1996 and 2016.
“the spending on low back and neck pain increased by 6.7% (95% CI, 6.1%-7.4%)annually between 1996 and 2016”
Quote in the paperSubstantial claim - Findingown data
For low back and neck pain, 57.2% of modeled spending was paid by private insurance.
“the majority of the modeled spending (57.2%[95% CI, 52.2%-61.2%])was paid by private insurance”
Quote in the paperSubstantial claim - Findingown data
Spending on dementias increased from an estimated $38.6 billion in 1996 to an estimated $79.2 billion in 2016.
“spending on dementias increased from an estimated $38.6 billion (95% CI, $34.1 billion-$42.8billion) in 1996 to an estimated $79.2 billion (95% CI, $67.6 billion-$90.8billion) in 2016.”
Quote in the paperNot a substantial claim - Findingown data
Spending on falls was greatest at older ages.
“Figure 3E shows that spending on falls was greatest at older ages”
Quote in the paperNot a substantial claim - Findingown data
In 2016, the health conditions with the highest out-of-pocket payments were oral disorders and well dental.
“the health conditions with the highest out-ofpocket payments were oral disorders and well dental.”
Quote in the paperNot a substantial claim - Findingown data
For falls, there was a transition from private financing to public financing at age 65 years.
“with a transition from private financing to public financing at aged 65 years”
Quote in the paperNot a substantial claim - Findingown data
Between 1996 and 2016, 53.7% of ambulatory care was paid by private insurance.
“Between 1996 and 2016, 53.7% (95% CI, 53.7%-53.7%) of ambulatory care was paid by private insurance”
Quote in the paperNot a substantial claim - Findingown data
Multiple sclerosis had an annual private insurance spending growth rate of 10.8% (95% CI, 7.5%-14.3%).
“multiple sclerosis (10.8% [95% CI, 7.5%-14.3%])”
Quote in the paperNot a substantial claim - Findingown data
Several of the health conditions with the highest spending have had substantial spending increases over the past 2 decades.
“Several of the health conditions with the highest spending have had substantial spending increases over the past 2 decades.”
Quote in the paperNot a substantial claim - Findingreasoning
The highest spending on dementias was among older women.
“Figure 4C shows that the highest spending was among older women with dementias”
Quote in the paperNot a substantial claim - Findingown data
Public insurance paid 57.8% of nursing care facility stays.
“Spending paid by public insurance was 57.8% (95% CI, 57.8%-57.8%)for nursing care facility stays”
Quote in the paperNot a substantial claim - Findingown data
Hyperlipidemia had an annual public insurance spending growth rate of 9.3% (95% CI, 8.2%-10.4%).
“hyperlipidemia (9.3% [95% CI, 8.2%-10.4%])”
Quote in the paperNot a substantial claim - Findingown data
Across 1996-2016, out-of-pocket payments were 4.2% of inpatient care.
“with little spending paid by out-of-pocket payments (4.2% [95% CI, 4.2%-4.2%]and 4.5% [95% CI, 4.5%-4.5%],respectively).”
Quote in the paperNot a substantial claim - Findingown data
In 2016, the highest amount of private insurance spending was for women and men aged 60 to 64 years.
“The highest amount of private insurance spending in 2016 was for women and men aged 60 to 64 years.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, private insurance spending generally increased with age from birth until aged 64 years.
“Private insurance spending generally increased with age from birth until aged 64 years.”
Quote in the paperNot a substantial claim - Findingown data
Among the 10 health conditions with the highest spending, dementias had the highest fraction of spending during nursing care facility stays.
“dementias had the highest fraction of spending during nursing care facility stays.”
Quote in the paperNot a substantial claim - Findingown data
Between 1996 and 2016, public insurance share of ambulatory care spending increased from 33.1% to 39.6%.
“with increases from 33.1% (95% CI, 33.1%-33.1%)to 39.6% (95% CI, 39.6%-39.6%) in spending paid by public insurance.”
Quote in the paperNot a substantial claim - Findingown data
Other musculoskeletal disorders had a similar funding pattern as low back and neck pain, with more financing from private insurance for those younger than aged 65 years.
“Figure 3B shows that other musculoskeletal disorders had a similar funding pattern as low back and neck pain, with more financing from private insurance for those younger than aged 65 years.”
Quote in the paperNot a substantial claim - Findingown data
As part of the adjustments, spending increased the most for dementias, chronic kidney disease, urinary disease, and heart failure.
“Spending on dementias, chronic kidney disease, urinary disease, and heart failure increased the most.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, public insurance spending was highest for those aged 65 years or older.
“In 2016, public insurance spending was highest for those aged 65 years or older.”
Quote in the paperNot a substantial claim - Findingown data
Public insurance share of prescribed pharmaceutical care spending increased from 19.1% in 1996 to 40.6% in 2016.
“spending paid by public insurance increased substantially from 19.1% (95% CI, 19.1%-19.2%) in 1996 to 40.6% (95% CI, 40.4%-40.8%) in 2016”
Quote in the paperNot a substantial claim - Findingown data
Across 1996-2016, 47.7% of ED care was paid by public insurance.
“47.7% (95% CI, 47.7%-47.7%) of ED care were paid by public insurance”
Quote in the paperNot a substantial claim - Findingown data
Hemoglobinopathies and hemolytic anemias had an annual out-of-pocket spending growth rate of 18.3% (95% CI, 7.7%-23.7%).
“hemoglobinopathies and hemolytic anemias (18.3% [95% CI, 7.7%-23.7%])”
Quote in the paperNot a substantial claim - Findingown data
Indirect maternal complications due to a preexisting condition had an annual private insurance spending growth rate of 10.8% (95% CI, 4.6%-18.2%).
“indirect maternal complications due to a preexisting condition (10.8% [95% CI, 4.6%-18.2%])”
Quote in the paperNot a substantial claim - Findingown data
Spending on osteoarthritis was roughly split between public and private insurance.
“with spending roughly split between public and private insurance”
Quote in the paperNot a substantial claim - Findingown data
Of the 5 health conditions with the highest spending in 2016, low back and neck pain and diabetes had the highest increases in absolute terms.
“Of the 5 health conditions with the highest spending in 2016, low back and neck pain and diabetes had the highest increases (in absolute terms).”
Quote in the paperNot a substantial claim - Findingnone given
Between 1996 and 2016, 108 of the 154 (70.1%) health conditions increased their spending after adjusting for population growth and aging.
“Between 1996 and 2016, 108 of the 154 (70.1%) health conditions increased their spending after adjusting for population growth and aging.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, the health conditions with the highest public insurance spending were diabetes and ischemic heart disease.
“The health conditions with the highest public insurance spending were diabetes and ischemic heart disease”
Quote in the paperSubstantial claim - Findingown data
Rheumatoid arthritis had an annual out-of-pocket spending growth rate of 11.2% (95% CI, 7.8%-14.7%).
“rheumatoid arthritis (11.2% [95% CI, 7.8%-14.7%])”
Quote in the paperNot a substantial claim - Findingreasoning
Spending on other musculoskeletal disorders was higher for women than men, especially between the ages of 40 and 70 years.
“Unlike low back and neck pain, spending on other musculoskeletal disorders was higher for women than men, especially between the ages of 40 and 70 years.”
Quote in the paperNot a substantial claim - Findingown data
Spending for ischemic heart disease occurs generally later in life.
“Similarly, Figure 3D shows that spending for ischemic heart disease occurs generally later in life.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, well dental care was among the health conditions with the highest spending paid by out-of-pocket payments, with estimated spending of $21.1 billion (95% CI, $20 billion-$22.6 billion).
“well dental care (an estimated $21.1 billion [95% CI, $20 billion-$22.6billion])”
Quote in the paperNot a substantial claim - Findingown data
Spending on dementias increased substantially.
“Spending on dementias and diabetes also increased substantially.”
Quote in the paperNot a substantial claim - Findingown data
In 2016, spending on low back and neck pain, other musculoskeletal disorders, diabetes, ischemic heart disease, and falls was greater than on other health conditions.
“In 2016, there was more health care spending on low back and neck pain, other musculoskeletal disorders, diabetes, ischemic heart disease, and falls than other health conditions.”
Quote in the paperSubstantial claim - Findingown data
Across time, the composition of which payers contributed spending in each type of care has changed little.
“Figure 6 shows that across time, the composition of which payers contributed spending in each type of care has changed little.”
Quote in the paperNot a substantial claim - Findingown data
Spending for hypertension occurs later in life.
“Figure 4D shows that spending for hypertension occurs later in life”
Quote in the paperNot a substantial claim - Findingown data
Across all years, 49.1% of prescribed pharmaceutical care spending was paid by private insurance.
“Although 49.1% (95% CI, 49.0%-49.1%) of prescribed pharmaceutical care spending was paid by private insurance across all years”
Quote in the paperNot a substantial claim - Findingown data
After adjusting for inflation, population size, and age groups, private insurance spending increased at an annualized rate of 2.6% between 1996 and 2016.
“2.6% (95% CI, 2.6%-2.6%)for private insurance”
Quote in the paperSubstantial claim - Findingown data
By 2016, private insurance accounted for 48.0% of total health spending.
“48.0% (95% CI, 48.0%-48.0%)by private insurance”
Quote in the paperNot a substantial claim - Findingreasoning
As part of the adjustments, spending decreased the most for septicemia, falls, and lower respiratory tract infection.
“Spending on septicemia, falls, and lower respiratory tract infection decreased the most.”
Quote in the paperNot a substantial claim - Findingown data
Spending for hypertension is primarily funded by public insurance.
“and primarily funded by public insurance”
Quote in the paperNot a substantial claim - Findingown data
Multiple sclerosis had an annual public insurance spending growth rate of 8.8% (95% CI, 7.1%-10.7%).
“multiple sclerosis (8.8% [95% CI, 7.1%-10.7%])”
Quote in the paperNot a substantial claim - Findingown data
For urinary diseases, spending was higher among women aged 20 to 40 years.
“while there was higher spending on urinary diseases among women aged 20 to 40 years”
Quote in the paperNot a substantial claim - Findingown data
Non-Hodgkin lymphoma had an annual out-of-pocket spending growth rate of 12.7% (95% CI, 8.8%-15.8%).
“non-Hodgkin lymphoma (12.7% [95% CI, 8.8%-15.8%])”
Quote in the paperNot a substantial claim - Findingown data
In 2016, low back and neck pain was among the health conditions with the highest spending funded by private insurance, with estimated spending of $76.9 billion (95% CI, $66.8 billion-$88 billion).
“low back and neck pain (an estimated $76.9 billion [95% CI, $66.8 billion-$88 billion])”
Quote in the paperNot a substantial claim - Findingnone given
Some health conditions with the highest changes in health care spending were also those that had an introduction of specialty drug treatment within the course of the current study, including hepatitis, rheumatoid arthritis, multiple sclerosis, and osteoarthritis.
“some of the health conditions with the highest changes in health care spending were also those that had an introduction of specialty drug treatment within the course of the current study, including hepatitis, rheumatoid arthritis, multiple sclerosis, and osteoarthritis.”
Quote in the paperNot a substantial claim - Study design and conductown data
The study included 85.2% of health care spending between 1996 and 2016.
“85.2% of that spending was included in this study.”
- Also stated in: § Results · plain
“The data reflected 85.2% of health care spending between 1996 and 2016.”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Interpretationown data
The increase in public insurance share of prescribed pharmaceutical spending in 2006 was associated with the implementation of Medicare Part D.
“with an increase in 2006 associated with the implementation of Medicare Part D.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Spending on dementias is likely to continue to increase as baby boomers age into the years most affected by the disease.
“Spending on dementias is likely to continue to increase as baby boomers age into the years most affected by the disease.”
Quote in the paperNot a substantial claim- Rests on an assumption: Baby boomers will age into the years most affected by dementia.
- Study design and conductown data
Health conditions routinely coded as secondary or as a comorbidity had spending increased in the adjustments if the microdata showed they were systematically associated with higher spending.
“Health conditions routinely coded as secondary or as a comorbidity had spending increased as part of our adjustments if the microdata showed they were systematically associated with higher spending.”
Quote in the paperSubstantial claim - Premisecitation
The number of prevalent cases of low back and neck pain increased by 1.1% annually.
“the number of prevalent cases increased by only 1.1% annually”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] 25. Substance Abuse and Mental Health Services Administration. Results from the 2016 national survey on drug use and health: detailed tables. http://www.samhsa.gov/data/report/results-2016- national-survey-drug-use-and-health-detailed- tables. Published September 7, 2017. Accessed January 23, 2020. source
- Premisecitation
There is a lack of data demonstrating that newer therapies for low back pain are any more effective than traditional low-cost treatments.
“the lack of data demonstrating that newer therapies are any more effective than traditional low-cost treatments.[26][27][28]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [26][27][28]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
A relatively large portion of spending for dementias was paid by out-of-pocket payments.
“a relatively large portion of spending for dementias was paid by out-of-pocket payments”
Quote in the paperSubstantial claim - Study design and conductown data
For health conditions routinely coded as a primary diagnosis but frequently having comorbidities that increased spending, spending was reduced in the adjustments.
“For health conditions that were routinely coded as a primary diagnosis but frequently had comorbidities present that increased spending, the spending was reduced.”
Quote in the paperSubstantial claim - Interpretationreasoning
Women with dementias have substantially higher spending for nursing care facility stays than men.
“and therefore have substantially higher spending for nursing care facility stays”
Quote in the paperSubstantial claim- Rests on an assumption: Women live longer than men on average.
- Rests on an assumption: Women are less likely to have an in-home informal caregiver (eg, a spouse) than men.
- Premisecitation
Recent growth in diabetes spending was fueled by increases in pharmaceutical spending.
“Spending on diabetes also increased, with the recent growth fueled by increases in pharmaceutical spending.21”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [21] 21. US Centers for Disease Control and Prevention; National Center for Health Statistics. National nursing home survey. https://www.cdc.gov/nchs/ nnhs/index.htm. Published January 10, 2018. Accessed March 30, 2018.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Study design and conductnone given
The study was unable to delineate spending by geographic region, income, race, or education level.
“it was unable to delineate spending by geographic region, income, race, or education level”
Quote in the paperNot a substantial claim - Study design and conductnone given
Additional data sources were used to improve the precision of the estimates.
“additional data sources were used to improve the precision of the estimates”
Quote in the paperSubstantial claim - Premisecitation
$74.9 billion of health care costs in 2013 were for uncompensated care received by those without insurance.
“It was estimated that $74.9 billion of the health care costs in 2013 were for uncompensated care received by those without insurance.30”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] 30. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010;116(14):3477-3484. doi:10. 1002/cncr.25150 source
- Study design and conductnone given
Spending on government administration and the net cost of insurance programs has been included.
“spending on government administration and the net cost of insurance programs has been included.”
Quote in the paperSubstantial claim - Premisecitation
The government pays a major portion of premiums for federal employee health benefits.
“the government pays a major portion of these premiums.31”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] 31. Hwang W, Weller W, Ireys H, Anderson G. Out-of-pocket medical spending for care of chronic conditions. Health Aff (Millwood). 2001;20(6): 267-278. doi:10.1377/hlthaff.20.6.267 source
- Study design and conductnone given
When the research was conducted (summer of 2019), the MEPS and the National Health Expenditure Accounts were the only data sources that provided 2017 data.
“When the research was conducted (summer of 2019), the MEPS and the National Health Expenditure Accounts were the only data sources that provided 2017 data”
Quote in the paperSubstantial claim - Study design and conductown data
These estimates identify which payer faces the highest burden of spending for a given disease and for each age group.
“These estimates also identify which payer faces the highest burden of spending for a given disease and for each age group.”
Quote in the paperSubstantial claim - Study design and conductreasoning
These sources were not deemed sufficient to make comprehensive estimates for 2017.
“these sources were not deemed sufficient to make comprehensive estimates for 2017.”
Quote in the paperSubstantial claim - Study design and conductnone given
These are the first estimates to disaggregate the administrative costs of insurance across health conditions and key patient demographics.
“these are the first estimates, to our knowledge, to disaggregate the administrative costs of insurance across health conditions and key patient demographics.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 21
- May combine two claims. 13
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSubsidies for employer-sponsored private insurance accounted for $146 billion of health care costs in 2017.
“Recent studies suggest that these subsidies accounted for $146 billion of health care costs in 2017.32”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [32] 32. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053): 1545-1602. doi:10.1016/S0140-6736(16)31678-6 source
The Methods (Data sources; page unavailable) describe insurance claims used to estimate disease prevalence, not the cost of employer-sponsored insurance subsidies. Searches for “$146 billion,” “2017,” and employer-sponsored insurance subsidies found no passage addressing the claimed amount. (LLM, conf=0.78)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataThe conditions with the highest spending varied by type of payer, age, sex, type of care, and year.
“The conditions with the highest spending varied by type of payer, age, sex, type of care, and year.”
- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
“Spending varied based on type of care, age, and payer.”
Quote in the paperSubstantial claim- Also stated in: § Health Care Spending by Payer and Health Condition in 2016 · plain
May combine two claims.
Findingown dataSpending on diabetes occurs later in life than low back and neck pain and other musculoskeletal disorders and is generally financed by public insurance.
“Figure 3C shows that spending on diabetes occurs later in life than low back and neck pain and other musculoskeletal disorders and is generally financed by public insurance.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThere was higher spending for ischemic heart disease among men at younger ages than among women, and higher spending among women at older ages than among men.
“However, there was higher spending for ischemic heart disease among men at younger ages than among women, and higher spending among women at older ages than among men.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor urinary diseases, spending was higher among men at older ages, with a major increase at age 55 years.
“there was higher spending among men at older ages with a major increase at aged 55 years”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPrivate insurance funded most of the modeled health care spending for low back and neck pain, whereas public insurance played a substantive role for the population aged 65 years or older, and out-of-pocket payments were relatively constant across age groups.
“Figure 3A shows that private insurance funded most of the modeled health care spending for low back and neck pain, whereas public insurance played a substantive role for the population aged 65 years or older, and out-of-pocket payments were relatively constant across age groups (when measured as a fraction of the total amount of low back and neck pain spending).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2016, out-of-pocket payments varied much less across age and sex than public and private insurance, with the highest spending among individuals older than 85 years.
“Out-of-pocket payments varied much less across age and sex than across public and private insurance, with the highest spending found among individuals older than aged 85 years.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe study estimated health care spending in 2016 for the 100 most expensive health conditions of the 154 analyzed.
“Health Care Estimated Spending in 2016 for the 100 Most Expensive Health Conditions of the 154 Health Conditions Analyzed”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe study estimated health care spending in 2016 for the 54 least expensive health conditions of the 154 analyzed.
“Health Care Estimated Spending in 2016 for the 54 Least Expensive of the 154 Health Conditions Analyzed”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe study analyzed 154 health conditions.
“154 Health Conditions Analyzed”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenBootstrapping methods only capture a subset of uncertainty and do not reflect the uncertainty associated with some modeling decisions and processes.
“Moreover, bootstrapping methods only capture a subset of uncertainty and do not reflect the uncertainty associated with some modeling decisions and processes.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Bootstrapping methods assume that the empirical distribution of the errors in the sample data approximates the population's distribution.
May combine two claims.
Interpretationown dataEstimates of US spending on health care showed substantial increases from 1996 through 2016, with the highest increases in population-adjusted spending by public insurance.
“Estimates of US spending on health care showed substantial increases from 1996 through 2016, with the highest increases in population-adjusted spending by public insurance.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataAlthough spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for the highest amounts of spending, the payers and the rates of change in annual spending growth rates varied considerably.
“Although spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for the highest amounts of spending, the payers and the rates of change in annual spending growth rates varied considerably.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductreasoningThe 95% CIs should be used as a relative indication of when the measurements are the most precise rather than as exact 95% CIs.
“Due to these limitations, the 95% CIs should be used as a relative indication of when the measurements are the most precise rather than as exact 95% CIs.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Bootstrapping methods assume that the empirical distribution of the errors in the sample data approximates the population's distribution.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe study excluded home health care (2.6% of total health care spending between 1996 and 2016), durable medical equipment and nondurable medical products (3.7%), government public health activities (2.9%), and research and infrastructure investment (5.6%).
“Excluded from this study were home health care (2.6% of total health care spending between 1996 and 2016); durable medical equipment and nondurable medical products, which include over-the-counter medicines (3.7%); government public health activities (2.9%); and research and infrastructure investment (5.6%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] 3. Emergency department care F 0 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Mean spending for 1996-2016, % Public insurance, 48.8 Private insurance, 47.0
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe health burden of low back and neck pain, measured using disability-adjusted healthyears, increased by 1.3% annually.
“the health burden (measured using disability-adjusted healthyears) increased by only 1.3% annually.25”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] 25. Substance Abuse and Mental Health Services Administration. Results from the 2016 national survey on drug use and health: detailed tables. http://www.samhsa.gov/data/report/results-2016- national-survey-drug-use-and-health-detailed- tables. Published September 7, 2017. Accessed January 23, 2020.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe point estimate of a percentile interval bootstrap is not based on the observed data but is instead based on the mean of the bootstrap draws and can be skewed in some cases.
“In addition, the point estimate (ie, the reported value) of a percentile interval bootstrap is not based on the observed data but is instead based on the mean of the bootstrap draws and can be skewed in some cases.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Bootstrapping methods assume that the empirical distribution of the errors in the sample data approximates the population's distribution.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAt the time of publication, these estimates are 3 years out of date.
“these estimates are, at the time of publication, 3 years out of date.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductreasoningThe many statistical adjustments and modeling necessary to complete this study are only as strong as the underlying data.
“the many statistical adjustments and modeling necessary to complete this study are only as strong as the underlying data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningHealth care spending differs from actual health system costs.
“This study assessed health care spending, which for many reasons differs from actual health system costs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningIt is unclear if the health condition, age group, and sex distribution for this spending actually reflects regular health care spending paid by public insurance.
“However, it is unclear if the health condition, age group, and sex distribution for this spending actually reflects regular health care spending paid by public insurance.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSpecialty drugs contributed to 43% of net pharmaceutical spending across all health conditions despite being only 2% of the volume in 2016.
“it is estimated that specialty drugs contributed to 43% of net pharmaceutical spending across all health conditions despite only being 2% of the volume in 2016.29”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] 29. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307(18):1934-1940. doi:10.1001/jama.2012.3951 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe data used in this study are imperfect.
“First, the data used in this study are imperfect.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe study cannot make any claims regarding the efficiency and effectiveness of these spending amounts and whether the trends are best suited in meeting national objectives to optimize the value of health care spending overall.
“this study cannot make any claims regarding the efficiency and effectiveness of these spending amounts and whether the trends are best suited in meeting national objectives to optimize the value of health care spending overall.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Study design and conductnone givenThis classification aligns with US government accounting in the National Health Expenditure Accounts.
“This classification aligns with US government accounting in the National Health Expenditure Accounts”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe estimates extend 3 additional years through 2016 compared to prior estimates.
“the estimates extend 3 additional years through 2016”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study did not provide granular and potentially distinct spending trends associated with Medicare and Medicaid separately.
“the study did not provide granular and potentially distinct spending trends associated with the 2 major government insurance programs, Medicare and Medicaid”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenMEPS and other data sources exclude active military personnel, incarcerated individuals, and homeless individuals.
“the MEPS and other data sources exclude active military personnel, incarcerated individuals, and homeless individuals.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningPayers with the highest spending for each health condition may have been underrepresented in the survey data due to the infrequency in which these cases occur.
“the payers with the highest spending for each health condition may have been underrepresented in the survey data due to the infrequency in which these cases occur.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThese subsidies are indirect contributions from the government and explain why these estimates do not account for the health care system's entire effect on the government.
“These subsidies are indirect contributions from the government and provide further explanation as to why these estimates do not account for the health care system's entire effect on the government.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningSpending was attributed to the entity that managed the spending rather than the originating source of the resources.
“In the current study, spending was attributed to the entity that managed the spending rather than the originating source of the resources.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Little is known about how spending by each type of payer is divided across health conditions.
“Although the Centers for Medicare & Medicaid Services provides annual estimates of total health care spending for each of these programs, little is known about how spending by each type of payer is divided across health conditions.”
The authors state this as an assumption.
Bootstrapping methods assume that the empirical distribution of the errors in the sample data approximates the population's distribution.
“Bootstrapping methods assume that the empirical distribution of the errors in the sample data approximates the population's distribution.”
The paper relies on this without support.
Women live longer than men on average.
“on average, women live longer than men”
The paper relies on this without support.
Women are less likely to have an in-home informal caregiver (eg, a spouse) than men.
“are less likely to have an in-home informal caregiver (eg, a spouse)”
The paper relies on this without support.
Baby boomers will age into the years most affected by dementia.
“as baby boomers age into the years most affected by the disease”
The paper relies on this without support.
Out-of-pocket payments are not distributed evenly or according to individuals' ability to pay.
“the 9.4% (95% CI, 9.4%-9.4%)that is financed by out-of-pocket payments (in 2016) is not distributed evenly or in accordance to individuals' ability to pay.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Healthcare expenditure has become a significant component of global spending, and many health systems face challenges to improve efficiency and provide sustainable care.
“Healthcare expenditure has become a significant component of global spending14, and many health systems face challenges to improve efficiency and provide sustainable care15,16.”
From Early prediction of diagnostic-related groups and estimation of hospital cost by processing clinical notes (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Study coverage is reported as both 85.2% and 86.8%
MinorThe paper gives two different percentages for the share of health care spending included in the study over 1996-2016.
“The data reflected 85.2% of health care spending between 1996 and 2016.”
“During this period, 86.8% of this spending was included in this study.”
Cites
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253 · see citing works
Self-citationThe Statistical Analysis of Compositional Data
Aitchison, J. (1986) · doi:10.1007/978-94-009-4109-0 · Cited by 4,383 · see citing works
The Statistical Analysis of Compositional Data
Aitchison, J. (1982) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1982.tb01195.x · Cited by 3,457 · see citing works
A better lemon squeezer? maximum-likelihood regression with beta-distributed dependent variables.
Smithson, M., & Verkuilen, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.1.54 · Cited by 1,788 · see citing works
US spending on personal health care and public health, 1996-2013.
Dieleman, J. L., Baral, R., Birger, M., Bui, A. L., Bulchis, A., Chapin, A., Hamavid, H., Horst, C., Johnson, E. K., Joseph, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16885 · Cited by 1,044 · see citing works
Self-citationNeonatal Abstinence Syndrome and Associated Health Care Expenditures: United States, 2000-2009
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012) · JAMA · doi:10.1001/jama.2012.3951 · Cited by 907 · see citing works
Chou, R., Deyo, R. A., Friedly, J. L., Skelly, A. C., Weimer, M. B., Fu, R., Dana, T., Kraegel, P., Griffin, J. C., & Grusing, S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2458 · Cited by 876 · see citing works
Chou, R., Deyo, R., Friedly, J., Skelly, A., Hashimoto, R., Weimer, M., Fu, R., Dana, T., Kraegel, P., Griffin, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2459 · Cited by 855 · see citing works
Chang, A. Y., Cowling, K., Micah, A. E., Chapin, A., Chen, C. S., Ikilezi, G., Sadat, N., Tsakalos, G., Wu, J., Younker, T., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30841-4 · Cited by 520 · see citing works
Self-citationNeonatal Abstinence Syndrome and Associated Health Care Expenditures
Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2013) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000429117.48176.cc · Cited by 454 · see citing works
Out-Of-Pocket Medical Spending For Care Of Chronic Conditions
Hwang, W., Weller, W., Ireys, H., & Anderson, G. (2001) · Health Affairs · doi:10.1377/hlthaff.20.6.267 · Cited by 440 · see citing works
Factors associated with increases in US health care spending, 1996-2013.
Dieleman, J. L., Squires, E., Bui, A. L., Campbell, M., Chapin, A., Hamavid, H., Horst, C., Li, Z., Matyasz, T., Reynolds, A., et al. (2017) · JAMA · doi:10.1001/jama.2017.15927 · Cited by 347 · see citing works
Self-citationCancer treatment cost in the United States: Has the burden shifted over time?
Tangka, F. K., Trogdon, J. G., Richardson, L. C., Howard, D., Sabatino, S. A., & Finkelstein, E. A. (2010) · Cancer · doi:10.1002/cncr.25150 · Cited by 156 · see citing works
Spending on children’s personal health care in the United States, 1996-2013.
Bui, A. L., Dieleman, J. L., Hamavid, H., Birger, M., Chapin, A., Duber, H. C., Horst, C., Reynolds, A., Squires, E., Chung, P. J., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.4086 · Cited by 151 · see citing works
Self-citationForeman, K. J., Naghavi, M., & Ezzati, M. (2016) · Population Health Metrics · doi:10.1186/s12963-016-0082-4 · Cited by 56 · see citing works
Self-citationHealth Care Spending on Diabetes in the U.S., 1996–2013
Squires, E., Duber, H. C., Campbell, M., Cao, J., Chapin, A., Horst, C., Li, Z., Matyasz, T., Reynolds, A., Hirsch, I. B., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1376 · Cited by 40 · see citing works
Self-citationHamavid, H., Birger, M., Bulchis, A. G., Lomsadze, L., Joseph, J., Baral, R., Bui, A. L., Horst, C., Johnson, E., & Dieleman, J. L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157912 · Cited by 19 · see citing works
Self-citationDieleman, J. L., Baral, R., Johnson, E., Bulchis, A., Birger, M. L., Bui, A. L., Campbell, M., Chapin, A., Gabert, R., Hamavid, H., et al. (2017) · Health Economics Review · doi:10.1186/s13561-017-0166-2 · Cited by 19 · see citing works
Self-citation
Flagged first, then by citations
1 of the 19 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Morrisey, Health Insurance, 1
- CurrieJ, HoK, KellyBR, KuziemkoI. Who will be our moral conscience now? a tribute to Uwe Reinhardt. https://www.healthaffairs.org/do/10.1377/hblog20190805.922868/full/. Accessed February 4, 2020. · DOI
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · see citing works
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784 · see citing works
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01301-6 · Cited by 4,681 · see citing works
Self-citationJoglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,989 · see citing works
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800 · see citing works
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,206 · see citing works
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933 · see citing works
Chen, S., Cao, Z. L., Klaus Prettner, A., Kühn, M., Yang, J., Jiao, L., Wang, Z., Li, W., Geldsetzer, P., Bärnighausen, T., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2022.7826 · Cited by 915 · see citing works
Five insights from the Global Burden of Disease Study 2019
Murray, C. J. L., Abbafati, C., Abbas, K., Abbasi, M., Abbasi‐Kangevari, M., Abd-Allah, F., Abdollahi, M. R., Abedi, P., Abedi, A., Abolhassani, H., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31404-5 · Cited by 695 · see citing works
Self-citationGeorge, S. Z., Fritz, J. M., Silfies, S. P., Schneider, M. J., Beneciuk, J. M., Lentz, T. A., Gilliam, J. R., Hendren, S., & Norman, K. S. (2021) · Journal of Orthopaedic & Sports Physical Therapy · doi:10.2519/jospt.2021.0304 · Cited by 607 · see citing works
Neck pain: global epidemiology, trends and risk factors
Kazeminasab, S., Nejadghaderi, S. A., Amiri, P., Pourfathi, H., Araj-Khodaei, M., Sullman, M. J. M., Kolahi, A., & Safiri, S. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04957-4 · Cited by 683 · see citing works
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 499 · see citing works
Chen, S., Kühn, M., Klaus Prettner, A., Yu, F., Yang, T., Bärnighausen, T., Bloom, D. E., & Wang, C. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00217-6 · Cited by 497 · see citing works
Chen, S., Chen, M., Wu, X., Lin, S., Tao, C., Cao, H., Shao, Z., & Xiao, G. (2021) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2021.07.005 · Cited by 477 · see citing works
Humphreys, K. N., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 463 · see citing works
Safiri, S., Kolahi, A., Cross, M., Hill, C. L., Smith, E. U. R., Carson‐Chahhoud, K., Mansournia, M. A., Almasi‐Hashiani, A., Ashrafi‐Asgarabad, A., Kaufman, J. S., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41571 · Cited by 390 · see citing works
Mahajan, S., Caraballo, C., Lu, Y., Valero-Elizondo, J., Massey, D., Annapureddy, A. R., Roy, B., Riley, C., Murugiah, K., Onuma, O., et al. (2021) · JAMA · doi:10.1001/jama.2021.9907 · Cited by 368 · see citing works
“Age, median (IQR), y 41 (30-55) 42 (29-55) 38 (28-50) 47 (33-61) Age category, y 18-39 45.”
Ng, M., Dai, X., Cogen, R. M., Abdelmasseh, M., Abdollahi, A., Abdullahi, A., Aboagye, R. G., Abukhadijah, H. J., Adeyeoluwa, T. E., Afolabi, A. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01548-4 · Cited by 369 · see citing works
Stevans, J. M., Delitto, A., Khoja, S. S., Patterson, C. G., Smith, C., Schneider, M., Freburger, J. K., Greco, C. M., Freel, J. A., Sowa, G., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37371 · Cited by 318 · see citing works
The Lancet Series call to action to reduce low value care for low back pain: an update
Buchbinder, R., Underwood, M., Hartvigsen, J., & Maher, C. G. (2020) · Pain · doi:10.1097/j.pain.0000000000001869 · Cited by 300 · see citing works
Lumbar Disc Herniation: Diagnosis and Management
Zhang, A. S., Xu, A. Y., Ansari, K., Hardacker, K. D., Anderson, G., Alsoof, D., & Daniels, A. H. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2023.03.024 · Cited by 275 · see citing works
Palaniappan, L. P., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 310 · see citing works
Manchikanti, L. (2020) · Pain Physician · doi:10.36076/ppj.2020/23/e71 · Cited by 224 · see citing works
“Health care expenditures are expected to skyrocket, along with economic strain on many sectors of the economy (14,15).”
BackgroundEconomic burden of childhood overweight and obesity: A systematic review and meta‐analysis
Ling, J., Chen, S., Zahry, N. R., & Kao, T. A. (2022) · Obesity Reviews · doi:10.1111/obr.13535 · Cited by 224 · see citing works
“patient, defensive medicine, insurance system, and free rider programs.(53,54) Therefore, the validity of the study's results may be reduced because of the increasing healthcare expenditures and”
BackgroundThe Economic Burden of Multiple Sclerosis in the United States
Bebo, B., Cintina, I., LaRocca, N., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200150 · Cited by 200 · see citing works
Cillekens, B., Lang, M., van Mechelen, W., Verhagen, E. A. L. M., Huysmans, M. A., Holtermann, A., van der Beek, A. J., & Coenen, P. (2020) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102587 · Cited by 183 · see citing works
“Particularly since musculoskeletal disorders, such as (low) back and neck pain, result in considerable healthcare spending, 80 as well as substantial indirect cost due to presen-teeism and absenteeism, 81 and are among the leading causes of disability worldwide.”
Pedroza, P., Miller-Petrie, M. K., Chen, C., Chakrabarti, S., Chapin, A., Hay, S., Tsakalos, G., Wimo, A., & Dieleman, J. L. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101337 · Cited by 177 · see citing works
Self-citationFerreira, G. E., Lin, C. C., Zadro, J. R., O’Keeffe, M., Shaheed, C. A., McLachlan, A. J., & Maher, C. G. (2021) · BMJ · doi:10.1136/bmj.m4825 · Cited by 171 · see citing works
Osteoarthritis year in review 2020: epidemiology & therapy
Peat, G., & Thomas, M. J. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.10.007 · Cited by 163 · see citing works
Xu, B., Wu, Q., La, R., Lu, L., Abdu, F. A., Yin, G., Zhang, W., Ding, W., Ling, Y., He, Z., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02251-w · Cited by 159 · see citing works
“Within the US, expenditures on CVD and DM healthcare have reached $89.3billion and $111.2bil-lion respectively, ranking as the fourth and third highest healthcare costs and exerting considerable pressure on health care resources [2].”
BackgroundBirger, M. L., Kaldjian, A. S., Roth, G. A., Moran, A. E., Dieleman, J. L., & Bellows, B. K. (2021) · Circulation · doi:10.1161/circulationaha.120.053216 · Cited by 150 · see citing works
Self-citationSandal, L. F., Bach, K., Øverås, C. K., Svendsen, M. J., Dalager, T., Jensen, J. S. D., Kongsvold, A., Nordstoga, A. L., Bardal, E. M., Ashikhmin, I., et al. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.4097 · Cited by 152 · see citing works
Chou, R. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202108170 · Cited by 159 · see citing works
Weng, Q., Chen, Q., Jiang, T., Zhang, Y., Zhang, W., Doherty, M., Xie, J., Liu, K., Li, J., Yang, T., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225324 · Cited by 136 · see citing works
“26 Subsequently, we estimate a correction factor (country-specific spending ratio) by using the ratio of total healthcare expenditures of each country to that of the USA (as a reference).”
MethodShin, D. W., Shin, J. I., Koyanagi, A., Jacob, L., Smith, L., Lee, H., Chang, Y., & Song, T. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.955367 · Cited by 120 · see citing works
Gresham, R. C. H., Bahney, C. S., & Leach, J. K. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.012 · Cited by 110 · see citing works
Cashin, A. G., Folly, T., Bagg, M. K., Wewege, M. A., Jones, M. D., Ferraro, M. C., Leake, H. B., Rizzo, R. R. N., Schabrun, S. M., Gustin, S. M., et al. (2021) · BMJ · doi:10.1136/bmj.n1446 · Cited by 116 · see citing works
Briggs, A. M., Shiffman, J., Shawar, Y. R., Åkesson, K., Ali, N., & Woolf, A. D. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101549 · Cited by 104 · see citing works
Volgman, A. S., Benjamin, E. J., Curtis, A. B., Fang, M. C., Lindley, K. J., Naccarelli, G. V., Pepine, C. J., Quesada, O., Vaseghi, M., Waldo, A. L., et al. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14838 · Cited by 104 · see citing works
“8) billion in 2016.(2) Also troubling is the prediction that the incidence of AF is expected to con-”
BackgroundWallwork, S. B., BRAITHWAITE, F., O’Keeffe, M., Travers, M. J., Summers, S. J., Lange, B. S., Hince, D., Costa, L. O. P., Costa, L. D. C. M., Chiera, B., et al. (2024) · Canadian Medical Association Journal · doi:10.1503/cmaj.230542 · Cited by 101 · see citing works
Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews
Cashin, A. G., Wand, B. M., O'Connell, N. E., Lee, H., Rizzo, R. R. N., Bagg, M. K., O’Hagan, E. T., Maher, C. G., Furlan, A. D., van Tulder, M. W., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013815.pub2 · Cited by 112 · see citing works
Delitto, A., Patterson, C. G., Stevans, J. M., Freburger, J. K., Khoja, S. S., Schneider, M., Greco, C. M., Freel, J. A., Sowa, G., Wasan, A. D., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100795 · Cited by 99 · see citing works
“In terms of cost, spinal pain represents the most costly health care condition in the US with estimates exceeding $134 billion [7].”
US Health Care Spending by Race and Ethnicity, 2002-2016
Dieleman, J. L., Chen, C., Crosby, S. W., Liu, A., McCracken, D., Pollock, I. A., Sahu, M., Tsakalos, G., Dwyer‐Lindgren, L., Haakenstad, A., et al. (2021) · JAMA · doi:10.1001/jama.2021.9937 · Cited by 94 · see citing works
Self-citationBussières, A., Hancock, M. J., Elklit, A., Ferreira, M. L., Ferreira, P. H., Stone, L. S., Wideman, T. H., Boruff, J. T., Zoubi, F. A., Chaudhry, F., et al. (2023) · European Journal of Psychotraumatology · doi:10.1080/20008066.2023.2284025 · Cited by 94 · see citing works
“Our fi ndings suggest ACE exposure is associated with the most common and costly chronic pain conditions, including back and neck pain and other MSDs, which account for the highest total health care spending compared to other health conditions (Dieleman et al., 2020).”
Kasch, R., Truthmann, J., Hancock, M. J., Maher, C. G., Otto, M., Nell, C., Reichwein, N., Bülow, R., Chenot, J., Hofer, A., et al. (2021) · Spine · doi:10.1097/brs.0000000000004198 · Cited by 96 · see citing works
Chen, N., Fong, D., & Wong, J. Y. H. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50674 · Cited by 93 · see citing works
Grogans, S. E., Bliss‐Moreau, E., Buss, K. A., Clark, L. A., Fox, A. S., Keltner, D. J., Cowen, A., Kim, J. J., Kragel, P. A., MacLeod, C., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105237 · Cited by 125 · see citing works
“…States alone, nearly 1 in 3 individuals will experience an anxiety disorder in their lifetime, diagnoses and service utilization are surging among young people, and direct health care costs exceed $40 billion annually (Binkley and Fenn, 2019; Dieleman et al., 2020; NCS-R, 2007; Vos et al., 2016).”
BackgroundEconomic Burden of Health Conditions Associated With Adverse Childhood Experiences Among US Adults
Peterson, C., Aslam, M. V., Niolon, P. H., Bacon, S., Bellis, M. A., Mercy, J. A., & Florence, C. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.46323 · Cited by 91 · see citing works
Healthcare spending for non-fatal falls among older adults, USA
Haddad, Y. K., Miller, G. F., Kakara, R. S., et al. (2024) · Injury Prevention · doi:10.1136/ip-2023-045023 · Cited by 87 · see citing works
The Amygdala and Depression: A Sober Reconsideration
Grogans, S. E., Fox, A. S., & Shackman, A. J. (2022) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220412 · Cited by 82 · see citing works
Hill‐Briggs, F., Ephraim, P. L., Vrany, E. A., Davidson, K. W., Pekmezaris, R., Salas‐Lopez, D., Alfano, C. M., & Gary‐Webb, T. L. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01454-3 · Cited by 82 · see citing works
“Diabetes has ranked highest among chronic diseases in US health care and public health spending [2].”
BackgroundBriggs, A. M., Schneider, C. H., Slater, H., Jordan, J. E., Parambath, S., Young, J. J., Sharma, S., Kopansky-Giles, D. R., Mishrra, S., Åkesson, K., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006045 · Cited by 83 · see citing works
Bolnick, H. J., Bui, A. L., Bulchis, A., Chen, C., Chapin, A., Lomsadze, L., Mokdad, A. H., Millard, F., & Dieleman, J. L. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30203-6 · Cited by 79 · see citing works
Self-citationPalacios‐Ceña, D., Albaladejo‐Vicente, R., Hernández‐Barrera, V., Florêncio, L. L., Fernández‐de‐las‐Peñas, C., Jiménez‐García, R., López‐de‐Andrés, A., de Miguel‐Díez, J., & Pérez‐Farinós, N. (2020) · Pain Medicine · doi:10.1093/pm/pnaa368 · Cited by 80 · see citing works
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016
Singh, S., Qian, A. S., Nguyen, N. H., Ho, S. K. M., Luo, J., Jairath, V., Sandborn, W. J., & Ma, C. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab074 · Cited by 77 · see citing works
COVID-19 and the Opioid Epidemic: Two Public Health Emergencies That Intersect With Chronic Pain
Manchikanti, L., Vanaparthy, R., Atluri, S. L., Sachdeva, H., Kaye, A. D., & Hirsch, J. A. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00243-2 · Cited by 75 · see citing works
Castellini, G., Pillastrini, P., Vanti, C., Bargeri, S., Giagio, S., Bordignon, E., Fasciani, F., Marzioni, F., Innocenti, T., Chiarotto, A., et al. (2022) · Journal of physiotherapy · doi:10.1016/j.jphys.2022.09.007 · Cited by 84 · see citing works
Bezzina, A., Austin, E. K., Nguyen, H., & James, C. L. (2023) · Workplace Health & Safety · doi:10.1177/21650799231193578 · Cited by 96 · see citing works
Marshall, A., Joyce, C. T., Tseng, B., Gerlovin, H., Yeh, G. Y., Sherman, K. J., Saper, R. B., & Roseen, E. J. (2021) · Pain Medicine · doi:10.1093/pm/pnab318 · Cited by 71 · see citing works
Epidural Steroid Injections for Low Back Pain: A Narrative Review
Carassiti, M., Pascarella, G., Strumia, A., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010231 · Cited by 71 · see citing works
Allocation of National Institutes of Health Funding by Disease Category in 2008 and 2019
Ballreich, J. M., Gross, C. P., Powe, N. R., & Anderson, G. F. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.34890 · Cited by 71 · see citing works
Health Care Spending on Respiratory Diseases in the United States, 1996–2016
Duan, K. I., Birger, M. L., Au, D. H., Spece, L. J., Feemster, L. C., & Dieleman, J. L. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0294oc · Cited by 70 · see citing works
Self-citationResearch Priorities in Atrial Fibrillation Screening
Benjamin, E. J., Go, A. S., Desvigne-Nickens, P. M., Anderson, C. D., Casadei, B., Chen, L. Y., Crijns, H. J. G. M., Freedman, B., Hills, M. T., Healey, J. S., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.047633 · Cited by 69 · see citing works
Essien, U. R., Chiswell, K., Kaltenbach, L. A., Wang, T. Y., Fonarow, G. C., Thomas, K. L., Turakhia, M. P., Benjamin, E. J., Rodríguez, F., Fang, M. C., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3704 · Cited by 67 · see citing works
Ma, C., Qian, A. S., Nguyen, N. H., Stukalin, I., Congly, S. E., Shaheen, A. A., Swain, M. G., Teriaky, A., Asrani, S. K., & Singh, S. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001292 · Cited by 68 · see citing works
“Data sources and study population Healthcare spending and health service utilizationwere estimated using publicly available data from the US Disease Expenditure (DEX) 2016 Project (15).”
BackgroundMethodInfluentialNguyen, N. H., Khera, R., Lucila Ohno-machado, A., Sandborn, W. J., & Singh, S. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.05.056 · Cited by 69 · see citing works
O’Keeffe, M., Ferreira, G. E., Harris, I. A., Darlow, B. J. S., Buchbinder, R., Traeger, A. C., Zadro, J. R., Herbert, R., Thomas, R., Belton, J. L., et al. (2022) · European Journal of Pain · doi:10.1002/ejp.1981 · Cited by 67 · see citing works
Kinge, J. M., Dieleman, J. L., Karlstad, Ø., Knudsen, A. K., Klitkou, S. T., Hay, S. I., Vos, T., Murray, C. J. L., & Vollset, S. E. (2023) · BMC Medicine · doi:10.1186/s12916-023-02896-6 · Cited by 70 · see citing works
“The 144 health conditions are presented as 14 aggregated conditions (Additional File 1, Supplementary Table 1) and are developed by the Institute for Health Metrics and Evaluations for the Disease Expenditure Project (DEX) [8].”
BackgroundMethodInfluentialSelf-citationMortality in atrial fibrillation. Is it changing?
Alonso, Á., Almuwaqqat, Z., & Chamberlain, A. M. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.010 · Cited by 67 · see citing works
Tsai, L., Nguyen, N. H., Ma, C., Prokop, L. J., Sandborn, W. J., & Singh, S. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-07200-1 · Cited by 64 · see citing works
Zhou, M., Theologis, A. A., & O’Connell, G. D. (2023) · JOR Spine · doi:10.1002/jsp2.1289 · Cited by 67 · see citing works
Wood, L., Bejarano, G., Csiernik, B., Miyamoto, G. C., Mansell, G., Hayden, J. A., Lewis, M., & Cashin, A. G. (2023) · Journal of physiotherapy · doi:10.1016/j.jphys.2023.05.008 · Cited by 62 · see citing works
Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries
Chow, R. D.-W., Bradley, E. H., & Gross, C. P. (2022) · JAMA Health Forum · doi:10.1001/jamahealthforum.2022.1229 · Cited by 61 · see citing works
Panebianco, C. J., Rao, S., Hom, W. W., Meyers, J., Lim, T. Y., Laudier, D. M., Hecht, A. C., Weir, M. D., Weiser, J. R., & Iatridis, J. C. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121641 · Cited by 59 · see citing works
Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals
Tahir, U. A., & Gerszten, R. E. (2023) · Circulation Research · doi:10.1161/circresaha.123.322000 · Cited by 72 · see citing works
Mattingly, T. J., Hyman, D. A., & Bai, G. (2023) · JAMA Health Forum · doi:10.1001/jamahealthforum.2023.3804 · Cited by 59 · see citing works
Pharmaceutical supply chain reliability and effects on drug shortages
Tucker, E. L., & Daskin, M. S. (2022) · Computers & Industrial Engineering · doi:10.1016/j.cie.2022.108258 · Cited by 59 · see citing works
Nguyen, N. H., Picetti, D., Dulai, P. S., Jairath, V., Sandborn, W. J., Lucila Ohno-machado, A., Chen, P. L., & Singh, S. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab155 · Cited by 60 · see citing works
Intervertebral disc degeneration and regeneration: a motion segment perspective
Ashinsky, B. G., Smith, H. E., Mauck, R. L., & Gullbrand, S. E. (2021) · European Cells and Materials · doi:10.22203/ecm.v041a24 · Cited by 60 · see citing works
Musculoskeletal health: an ecological study assessing disease burden and research funding
Nguyen, A. T., Aris, I. M., Snyder, B. D., Harris, M. B., Kang, J. D., Murray, M. M., Rodriguez, E. K., & Nazarian, A. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100661 · Cited by 58 · see citing works
Gao, T., Xu, G., Ma, T., Lu, X., Chen, K., Luo, H., Chen, G., Song, J. G., Ma, X., Fu, W. E., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401103 · Cited by 59 · see citing works
Li, Y., Pan, D., Wang, X., Huo, Z., Wu, X., Li, J., Cao, J., Xu, H., Du, L., & Xu, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4235126 · Cited by 54 · see citing works
“Increasing epidemiological data showed that lower back pain (LBP) is one of the most prevalent symptoms with a higher disability rate, contributing to enormous economic losses world-wide [1 – 3].”
Self-citationMannino, D. M., Roberts, M. H., Mapel, D. W., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.11.040 · Cited by 54 · see citing works
Cost of U.S emergency department and inpatient visits for fall injuries in older adults
Reider, L. M., Falvey, J. R., Okoye, S. M., Wolff, J. L., & Levy, J. F. (2023) · Injury · doi:10.1016/j.injury.2023.111199 · Cited by 55 · see citing works
PEER systematic review of randomized controlled trials
Kolber, M. R., Ton, J., Thomas, B., Kirkwood, J. E. M., Moe, S., Dugré, N., Chan, K., Lindblad, A. J., McCormack, J. P., Garrison, S., et al. (2021) · Canadian Family Physician · doi:10.46747/cfp.6701e20 · Cited by 53 · see citing works
Pan, M., Li, R., Wei, J., Peng, H., Hu, Z., Xiong, Y., Li, N., Guo, Y., Gu, W., & Liu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1506641 · Cited by 56 · see citing works
Tracking US Health Care Spending by Health Condition and County
Dieleman, J. L., Beauchamp, M., Crosby, S. W., DeJarnatt, D., Johnson, E. K., Lescinsky, H., McHugh, T. A., Pollock, I., Sahu, M., Swart, V. M., et al. (2025) · JAMA · doi:10.1001/jama.2024.26790 · Cited by 53 · see citing works
Self-citationKanbour, S., Ageeb, R. A., Malik, R. A., & Abu-Raddad, L. J. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00346-2 · Cited by 55 · see citing works
Bakooshli, M. A., Wang, Y. X., Monti, E., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg1485 · Cited by 51 · see citing works
Effect of Copayment on Dental Visits: A Regression Discontinuity Analysis
Cooray, U., Aida, J., Watt, R. G., et al. (2020) · Journal of Dental Research · doi:10.1177/0022034520946022 · Cited by 50 · see citing works
“Treatment of oral diseases is costly and often associated with high out-of-pocket expenditure for service users (Bernabé et al. 2017; Dieleman et al. 2020).”
BackgroundChen, N., Fong, D., & Wong, J. Y. H. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.44198 · Cited by 49 · see citing works
Liu, J., Capurro, D., Nguyen, A., & Verspoor, K. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00474-9 · Cited by 50 · see citing works
Transforming low back pain care delivery in the United States
George, S. Z., Goertz, C., Hastings, S. N., & Fritz, J. M. (2020) · Pain · doi:10.1097/j.pain.0000000000001989 · Cited by 49 · see citing works
Particularities of Urinary Tract Infections in Diabetic Patients: A Concise Review
Confederat, L. G., Condurache, I., Alexa, R.-E., & Dragostin, O.-M. (2023) · Medicina · doi:10.3390/medicina59101747 · Cited by 58 · see citing works
“Concerning the distribution of diabetes subtypes in terms of prevalence, the statistical information for the year 2021 indicates that 96% of the total reported cases were a tt ributed to type 2 diabetes.”
BackgroundRole of Pyroptosis in Intervertebral Disc Degeneration and Its Therapeutic Implications
Luo, J., Yang, Y., Wang, X., et al. (2022) · Biomolecules · doi:10.3390/biom12121804 · Cited by 48 · see citing works
The global macroeconomic burden of diabetes mellitus
Chen, S., Cao, Z., Chen, W., Zhao, J., Jiao, L., Klaus Prettner, A., Kühn, M., Pan, A., Bärnighausen, T., & Bloom, D. E. (2025) · Nature Medicine · doi:10.1038/s41591-025-04027-5 · Cited by 59 · see citing works
Panebianco, C. J., Dave, A., Charytonowicz, D., Sebra, R., & Iatridis, J. C. (2021) · The FASEB Journal · doi:10.1096/fj.202101149r · Cited by 45 · see citing works
Shao, T., Zhao, M., Liang, L., & Tang, W. (2023) · BioDrugs · doi:10.1007/s40259-023-00586-6 · Cited by 47 · see citing works
“This analysis was conducted from the perspective of US and Chinese payers (US payers: including public insurance, private insurance, and out-of-pocket payments [29]; Chinese payers: Chinese healthcare system).”
MethodRoseen, E. J., Smith, C., Essien, U. R., Cozier, Y. C., Joyce, C. T., Morone, N. E., Phillips, R. S., Barnett, K. G., Patterson, C. G., Wegener, S. T., et al. (2022) · Pain Medicine · doi:10.1093/pm/pnac193 · Cited by 47 · see citing works
- Authors
- Dieleman, J. L., Cao, J., Chapin, A., Chen, C., Li, Z., Liu, A., Horst, C., Kaldjian, A., Matyasz, T., Scott, K. W., Bui, A. L., Campbell, M., Duber, H. C., Dunn, A. C., Flaxman, A. D., Fitzmaurice, C., Naghavi, M., Sadat, N., Shieh, P., Squires, E., Yeung, K., & Murray, C. J. L.
- Affiliations
- Institute for Health Metrics and Evaluation (US)
- Harvard University (US)
- Seattle Children's Hospital (US)
- Meta (United States) (US)
- University of Washington (US)
- Bureau of Economic Analysis (US)
- Microsoft (United States) (US)
- The Improve Group, St Paul, Minnesota
- Kaiser Permanente Washington Health Research Institute (US)
- Corresponding author
- Dieleman, Joseph L.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2020-03-03
- Volume
- 323
- Issue
- 9
- Pages
- 863
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC7054840
- OpenAlex
- W3010268726
- Cited by
- 1,313
- References
- 19
- Citations by year
- 2026: 171 · 2025: 269 · 2024: 284 · 2023: 221 · 2022: 160 · 2021: 139 · 2020: 69
- FWCI
- 125.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG047845)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Health Sciences › Health Professions › General Health Professions › Global Health Care Issues
- Social Sciences › Economics, Econometrics and Finance › Finance › Healthcare Systems and Reforms
- Keywords
- health care spending, public insurance, private insurance, out-of-pocket costs, Medicare, Medicaid, health conditions, outpatient care, inpatient care, nursing facilities, emergency department care, dental care, prescription drug spending, health care costs
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Disease, Health Expenditures, Female, Health Status, Humans, Infant, Insurance, Health, Male, Middle Aged, United States, Age Distribution, Sex Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review